Back

Gain Therapeutics to present long-term rexaceract data at Parkinson’s congress in Seoul

Verifying
  • Gain Therapeutics announced a rexaceract poster presentation at the 2026 Parkinson’s congress.
  • October 7, 2026, presentation covers long-term data and runs 12:00-12:10 p.m. KST.
  • Rexaceract is undergoing a Phase 1b Parkinson’s trial across seven Australian sites.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.